Literature DB >> 20821208

A new PET probe, (18)F-tetrafluoroborate, for the sodium/iodide symporter: possible impacts on nuclear medicine.

Hyewon Youn, Jae Min Jeong, June-Key Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20821208     DOI： 10.1007/s00259-010-1601-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

1.  The accumulation of fluoroborate ions in thyroid glands of rats.

Authors:  M ANBAR; S GUTTMANN; Z LEWITUS
Journal:  Endocrinology       Date:  1960-06       Impact factor: 4.736

Review 2.  Overview of the management of differentiated thyroid cancer.

Authors:  Jyotika K Fernandes; Terry A Day; Mary S Richardson; Anand K Sharma
Journal:  Curr Treat Options Oncol       Date:  2005-01

3.  Translational research using the sodium/iodide symporter in imaging and therapy.

Authors:  June-Key Chung; Joo Hyun Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-10       Impact factor: 9.236

4.  Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.

Authors:  Susanne M Eschmann; Gerald Reischl; Kilian Bilger; Juergen Kupferschläger; Marcel H Thelen; Bernhard M Dohmen; Hariolf Besenfelder; Roland Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

5.  Effect of monofluorosulphonate, difluorophosphate and fluoroborate ions on the iodine uptake of the thyroid gland.

Authors:  M ANBAR; S GUTTMANN; Z LEWITUS
Journal:  Nature       Date:  1959-05-30       Impact factor: 49.962

Review 6.  Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

Authors:  June-Key Chung; Hye Won Youn; Joo Hyun Kang; Ho Young Lee; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

7.  124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact.

Authors:  L S Freudenberg; W Jentzen; R Görges; T Petrich; R J Marlowe; J Knust; A Bockisch
Journal:  Nuklearmedizin       Date:  2007       Impact factor: 1.379

8.  Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.

Authors:  B Caillou; F Troalen; E Baudin; M Talbot; S Filetti; M Schlumberger; J M Bidart
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

Authors:  George Sgouros; Katherine S Kolbert; Arif Sheikh; Keith S Pentlow; Edward F Mun; Axel Barth; Richard J Robbins; Steven M Larson
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

10.  Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter.

Authors:  Maite Jauregui-Osoro; Kavitha Sunassee; Amanda J Weeks; David J Berry; Rowena L Paul; Marcel Cleij; Jasvinder Paul Banga; Michael J O'Doherty; Paul K Marsden; Susan E M Clarke; James R Ballinger; Istvan Szanda; Sheue-Yann Cheng; Philip J Blower
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-25       Impact factor: 9.236
View more
  6 in total

1.  Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.

Authors:  Huailei Jiang; Aditya Bansal; Mukesh K Pandey; Kah-Whye Peng; Lukkana Suksanpaisan; Stephen J Russell; Timothy R DeGrado
Journal:  J Nucl Med       Date:  2016-04-21       Impact factor: 10.057

Review 2.  The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.

Authors:  Alan R Penheiter; Stephen J Russell; Stephanie K Carlson
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391

3.  Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects.

Authors:  Huailei Jiang; Nicholas R Schmit; Alex R Koenen; Aditya Bansal; Mukesh K Pandey; Robert B Glynn; Bradley J Kemp; Kera L Delaney; Angela Dispenzieri; Jamie N Bakkum-Gamez; Kah-Whye Peng; Stephen J Russell; Tina M Gunderson; Val J Lowe; Timothy R DeGrado
Journal:  EJNMMI Res       Date:  2017-10-27       Impact factor: 3.138

4.  Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate.

Authors:  J M Marti-Climent; M Collantes; M Jauregui-Osoro; G Quincoces; E Prieto; I Bilbao; M Ecay; J A Richter; I Peñuelas
Journal:  EJNMMI Res       Date:  2015-12-03       Impact factor: 3.138

5.  Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.

Authors:  Andrea M Müller; Kathrin A Schmohl; Kerstin Knoop; Christina Schug; Sarah Urnauer; Anna Hagenhoff; Dirk-André Clevert; Michael Ingrisch; Hanno Niess; Janette Carlsen; Christian Zach; Ernst Wagner; Peter Bartenstein; Peter J Nelson; Christine Spitzweg
Journal:  Oncotarget       Date:  2016-08-23

Review 6.  [18F]Tetrafluoroborate ([18F]TFB) and its analogs for PET imaging of the sodium/iodide symporter.

Authors:  Huailei Jiang; Timothy R DeGrado
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.